Buspirone 2.5-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue
Page(s): 424
Download in electronic PDF format for $65
Abstract: A formulation for preparing Buspirone 2.5-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
Loyd V. Allen, Jr., PhD, RPh, formulation, buspirone, anxiety disorder
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 424
|
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 487
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 340
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 57
|
Aminohippurate Sodium 250 mg/mL Infection
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 142
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|